The second injection of vaccine against coronavirus developed by Pfizer and BioNTech laboratories can be delayed by a few weeks in “exceptional circumstances”, experts from the World Health Organization ( WHO ).
The Strategic Advisory Group of Experts (SAGE) on Immunization “recommends the administration of two doses of this vaccine in a delay of 21 to 28 days ”, said during a press conference with its president, Alejandro Cravioto, while indicating that it was possible to delay the administration of the second injection by a few weeks “in exceptional circumstances of epidemiological contexts and supply constraints”. This will allow “to maximize the number of people benefiting from a first dose”, he explained.
No more than six weeks between the two doses
During this same press conference, Kate O’Brien, director of the immunization and vaccines department at the WHO, warned that the delay could not exceed six weeks.
This announcement by WHO experts comes as the BioNTech laboratory warned on Tuesday that the maximum effectiveness of its vaccine against Covid- 19 was not demonstrated if the second injection is delayed, strategy applied or considered by several countries to vaccinate more people. “The efficacy and safety of the vaccine have not been evaluated for other dosing schedules” than the two spaced injections of 20 days applied during the clinical trial, explained the German company, which developed with the American laboratory Pfizer the first vaccine authorized in the USA and the EU.
Faced with limited stocks of this product, Denmark announced Monday to space the two doses up to six weeks; the United Kingdom, which authorized the vaccine before the EU, at the beginning of December, is allowing until weeks between the two injections.
In Germany, the health ministry has asked health authorities to assess options to extend the deadline, according to a document consulted on Monday by AFP.
A list of recommendations for the vaccine
The WHO expert group made a whole series of recommendations on Tuesday regarding the Pfizer / BioNTech vaccine against Covid – 19. In particular, they recommend that the vaccine be administered only in settings where anaphylactic shock (a severe allergic reaction) can be treated.
Due to the lack of data on pregnant and breastfeeding women, experts prefer not to make recommendations for the moment. Alejandro Cravioto stressed, however, that “the benefits of immunizing pregnant women outweigh the potential risk” in some cases, such as in the case of health workers at high risk of contagion. And if a woman is in a high risk group, “we recommend vaccination without stopping breastfeeding,” he said.
In addition, the expert group does not currently recommend the vaccination of international travelers, unless ” they are not part of a high risk group.
Finally, noting that current data shows that symptomatic reinfection within six months of a first infection is rare, they recommend that people who test positive through a PCR test within the previous six months of delay vaccination until the end of this period.